Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic mice expressing human APP and TGF-&bgr; demonstrate cerebrovascular amyloid deposits

Transgenic mice expressing human APP and TGF-&bgr; demonstrate cerebrovascular amyloid deposits

US Patent 6455757 · Granted Sep 24, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions targeting 3-repeat tau for the treatment of neurodegenerative disor2021
Methods and compositions for reducing amyloid beta levels2016
Agents that reduce neuronal overexcitation2015
Methods of treating neurodegenerative disease2015
Agents that reduce neuronal overexcitation2015
Compounds for reversing and inhibiting protein aggregation, and methods for maki2015
Compound suitable for the treatment of synucleopathies2014
Prevention and treatment of synucleinopathic and amyloidogenic disease2014
Methods and compositions for reducing amyloid beta levels2014
Prevention and treatment of synucleinopathic and amyloidogenic disease2013
Compounds for inhibiting protein aggregation, and methods for making and using t2013
Methods and compositions for reducing amyloid beta levels2013